Search

everythinglearnresearchcommunity

for

Search:↓

A Cavalier King Charles Spaniel had both uveodermatological syndrome and alopecia areata, and treatment with ciclosporin helped regrow hair.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

Hair transplantation can effectively treat stable eyebrow hair loss in alopecia areata patients.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

Alopecia areata negatively affects the self-esteem and quality of life of children and teens.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

Vitiligo is a systemic disease with psychological effects, and new treatments focus on personalized care.

New hair loss treatments could be improved by using combined biological markers.

Alopecia areata causes hair loss and needs personalized care to manage its emotional and social effects.

Pregnancy can cause skin changes, some harmless and others risky, needing careful management.

Black women with alopecia need better support and understanding from health professionals and social groups.

Patients with Alopecia Areata often have higher anxiety and depression.

Hair extensions can worsen scalp conditions and should be avoided in those with alopecia.

AI can improve alopecia areata diagnosis with high accuracy.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

HairLossMultinet accurately classifies hair damage with 98% accuracy but needs a more diverse dataset for broader use.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.